Citadel Advisors - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2018$29,000
-81.0%
46,997
-60.0%
0.00%
Q3 2018$153,000
+66.3%
117,617
+74.1%
0.00%
Q2 2018$92,000
-5.2%
67,543
+57.8%
0.00%
Q4 2017$97,000
+162.2%
42,807
+289.2%
0.00%
Q3 2017$37,000
-39.3%
11,000
-36.2%
0.00%
Q2 2017$61,000
-37.1%
17,251
-18.2%
0.00%
Q2 2015$97,00021,1000.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,674,0001.12%
Northeast Financial Consultants Inc 732,265$1,061,0000.36%
Family Management Corp 10,424$15,0000.01%
AJ WEALTH STRATEGIES, LLC 15,000$22,0000.01%
Poehling Capital Management, INC. 3,302$5,0000.00%
A.R.T. Advisors, LLC 48,692$70,0000.00%
Virtu Financial LLC 34,383$50,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 151,854$220,0000.00%
BEACON INVESTMENT ADVISORY SERVICES, INC. 10,500$15,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders